Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase.
Intracellular activation of ricin and of the ricin A-chain (RTA) immunotoxins requires reduction of their intersubunit disulfide(s). This crucial event is likely to be catalyzed by disulfide oxidoreductases and precedes dislocation of the toxic subunit to the cytosol. We investigated the role of protein disulfide isomerase (EC 5.3.4.1, PDI), thioredoxin (Trx), and thioredoxin reductase (EC 1.8.1.9, TrxR) in the reduction of ricin and of a ricin A-chain immunotoxin by combining enzymatic assays, SDS-PAGE separation and immunoblotting. We found that, whereas PDI, Trx, and TrxR used separately were unable to directly reduce ricin and the immunotoxin, PDI and Trx in the presence of TrxR and NADPH could reduce both ricin and immunotoxin in vitro. PDI functioned only after pre-incubation with TrxR and the reductive activation of ricin was more efficient in the presence of glutathione. Similar results were obtained with microsomal membranes or crude cell extracts. Pre-incubation with the gold(I) compound auranofin, which irreversibly inactivates TrxR, resulted in a dose-dependent inhibition of ricin and immunotoxin reduction. Reductive activation of ricin and immunotoxin decreased or was abolished in microsomes depleted of TrxR and in cell extracts depleted of both PDI and Trx. Pre-incubation of U-937, Molt-3, Jurkat, and DU145 cells with auranofin significantly decreased ricin cytotoxicity with respect to mock-treated controls (P<0.05). Conversely, auranofin failed to protect cells from the toxicity of pre-reduced ricin which does not require intracellular reduction of disulfide between the two ricin subunits. We conclude that TrxR, by activating disulfide reductase activity of PDI, can ultimately lead to reduction/activation of ricin and immunotoxin in the cell.
Bellisola
Giuseppe
G
Department of Pathology, Section of Immunology, University of Verona, Policlinico G.B. Rossi, L.go L.A. Scuro 10, I-37134 Verona, Italy.
Fracasso
Giulio
G
Ippoliti
Rodolfo
R
Menestrina
Gianfranco
G
Rosén
Anders
A
Soldà
Silvia
S
Udali
Silvia
S
Tomazzolli
Rossella
R
Tridente
Giuseppe
G
Colombatti
Marco
M
D001310:Auranofin / Q000494:pharmacology; D006801:Humans; D000922:Immunotoxins / Q000378:metabolism; D009249:NADP; D010084:Oxidation-Reduction / Q000187:drug effects; D019704:Protein Disulfide-Isomerases / Q000378:metabolism*; D012276:Ricin / Q000378:metabolism*; D013880:Thioredoxin-Disulfide Reductase / Q000378:metabolism*; D020298:U937 Cells
D000922:Immunotoxins; D001310:Auranofin; D009249:NADP; D012276:Ricin; D013880:Thioredoxin-Disulfide Reductase; D019704:Protein Disulfide-Isomerases